CFM
IMCR icon

Cornerstone Financial Management’s Immunocore IMCR Stock Holding History

Cornerstone Financial Management’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$572 Buy
18
+1
+6% +$30 ﹤0.01% 1307
2026
Q1 		$513 Hold
17
– – ﹤0.01% 1186
2025
Q4 		$590 Buy
+17
New +$600 ﹤0.01% 1098

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Cornerstone Financial Management's IMCR Position: Q2 2026 in Review

Cornerstone Financial Management increased its Immunocore (IMCR) stake by 5.9% in Q2 2026, buying an estimated $30 and bringing the position to 18 shares worth $572. The position accounts for ﹤0.01% of the portfolio, ranked #1307.

Cornerstone Financial Management first reported a position in IMCR in Q4 2025 and has held it in 3 quarters since. The position peaked at $590 in Q4 2025. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Cornerstone Financial Management held 18 shares of Immunocore worth $572 as of Q2 2026.
  • Cornerstone Financial Management bought 1 Immunocore share in Q2 2026, an estimated $30.
  • Immunocore made up ﹤0.01% of Cornerstone Financial Management's portfolio in Q2 2026, its #1307 holding.
  • Cornerstone Financial Management first reported a position in Immunocore in Q4 2025 and has held it in 3 quarters since.
  • Cornerstone Financial Management's Immunocore position peaked at $590 in Q4 2025.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Cornerstone Financial Management's 13F filing for Q2 2026, filed 12 Aug 2026.